Phibro Animal Net Worth
Phibro Animal Net Worth Breakdown | PAHC |
Phibro Animal Net Worth Analysis
Phibro Animal's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Phibro Animal's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Phibro Animal's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Phibro Animal's net worth analysis. One common approach is to calculate Phibro Animal's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Phibro Animal's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Phibro Animal's net worth. This approach calculates the present value of Phibro Animal's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Phibro Animal's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Phibro Animal's net worth. This involves comparing Phibro Animal's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Phibro Animal's net worth relative to its peers.
To determine if Phibro Animal is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Phibro Animal's net worth research are outlined below:
| Phibro Animal Health generated a negative expected return over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Phibro Animal Health Sets Q2 2025 Earnings Release Date for February 5th - StockTitan |
Phibro Animal Quarterly Good Will |
|
Phibro Animal uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Phibro Animal Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Phibro Animal's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 7th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of September 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of June 2023 Last Financial Announcement | View |
Phibro Animal Target Price Consensus
Phibro target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Phibro Animal's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Hold |
Most Phibro analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Phibro stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Phibro Animal Health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationPhibro Animal Target Price Projection
Phibro Animal's current and average target prices are 21.98 and 19.40, respectively. The current price of Phibro Animal is the price at which Phibro Animal Health is currently trading. On the other hand, Phibro Animal's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Phibro Animal Market Quote on 30th of January 2025
Target Price
Analyst Consensus On Phibro Animal Target Price
Know Phibro Animal's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Phibro Animal is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Phibro Animal Health backward and forwards among themselves. Phibro Animal's institutional investor refers to the entity that pools money to purchase Phibro Animal's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Nuveen Asset Management, Llc | 2024-09-30 | 484.4 K | Dana Investment Advisors Inc | 2024-09-30 | 459.8 K | Castleknight Management Lp | 2024-09-30 | 366.6 K | Goldman Sachs Group Inc | 2024-09-30 | 343.3 K | Charles Schwab Investment Management Inc | 2024-09-30 | 268.4 K | Bank Of New York Mellon Corp | 2024-09-30 | 264.9 K | Aqr Capital Management Llc | 2024-09-30 | 256.3 K | Sofinnova Ventures | 2024-09-30 | 238.2 K | Arrowstreet Capital Limited Partnership | 2024-09-30 | 237.5 K | Blackrock Inc | 2024-09-30 | 3.6 M | Vanguard Group Inc | 2024-09-30 | 1.5 M |
Follow Phibro Animal's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 887.03 M.Market Cap |
|
Project Phibro Animal's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | 0.08 | 0.14 | |
| Return On Equity | 0.01 | 0.01 |
When accessing Phibro Animal's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Phibro Animal's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Phibro Animal's profitability and make more informed investment decisions.
Please note, the presentation of Phibro Animal's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Phibro Animal's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Phibro Animal's management manipulating its earnings.
Evaluate Phibro Animal's management efficiency
Phibro Animal Health has return on total asset (ROA) of 0.0526 % which means that it generated a profit of $0.0526 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0655 %, meaning that it created $0.0655 on every $100 dollars invested by stockholders. Phibro Animal's management efficiency ratios could be used to measure how well Phibro Animal manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to 0.14, whereas Return On Tangible Assets are forecasted to decline to 0. At present, Phibro Animal's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 210.4 M, whereas Total Assets are forecasted to decline to about 568.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.70 | 5.99 | |
| Tangible Book Value Per Share | 3.49 | 3.66 | |
| Enterprise Value Over EBITDA | 14.92 | 15.67 | |
| Price Book Value Ratio | 2.42 | 3.21 | |
| Enterprise Value Multiple | 14.92 | 15.67 | |
| Price Fair Value | 2.42 | 3.21 |
Examining the leadership quality of Phibro Animal Health offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 1.2506 | Revenue | Quarterly Revenue Growth 0.126 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Phibro Animal insiders, such as employees or executives, is commonly permitted as long as it does not rely on Phibro Animal's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Phibro Animal insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Corcoran E Thomas over three months ago Acquisition by Corcoran E Thomas of 5000 shares of Phibro Animal at 20.02 subject to Rule 16b-3 | ||
Daniel Bendheim over six months ago Disposition of 2500 shares by Daniel Bendheim of Phibro Animal at 11.83 subject to Rule 16b-3 | ||
Larry Miller over a year ago Acquisition by Larry Miller of 300000 shares of Phibro Animal subject to Rule 16b-3 |
Phibro Animal Corporate Filings
F3 | 28th of January 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 23rd of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 7th of January 2025 An amendment to a previously filed Form 8-K | ViewVerify |
F3 | 15th of November 2024 An amendment to the original Schedule 13D filing | ViewVerify |
Phibro Animal Earnings Estimation Breakdown
The calculation of Phibro Animal's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Phibro Animal is estimated to be 0.453 with the future projection ranging from a low of 0.399 to a high of 0.48. Please be aware that this consensus of annual earnings estimates for Phibro Animal Health is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.40 Lowest | Expected EPS | 0.48 Highest |
Phibro Animal Earnings Projection Consensus
Suppose the current estimates of Phibro Animal's value are higher than the current market price of the Phibro Animal stock. In this case, investors may conclude that Phibro Animal is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Phibro Animal's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 5 | 76.23% | 0.35 | 0.453 | 0.43 |
Phibro Animal Earnings per Share Projection vs Actual
Actual Earning per Share of Phibro Animal refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Phibro Animal Health predict the company's earnings will be in the future. The higher the earnings per share of Phibro Animal, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Phibro Animal Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Phibro Animal, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Phibro Animal should always be considered in relation to other companies to make a more educated investment decision.Phibro Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Phibro Animal's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-06 | 2024-09-30 | 0.25 | 0.35 | 0.1 | 40 | ||
2024-08-28 | 2024-06-30 | 0.33 | 0.41 | 0.08 | 24 | ||
2024-05-08 | 2024-03-31 | 0.29 | 0.31 | 0.02 | 6 | ||
2024-02-07 | 2023-12-31 | 0.28 | 0.33 | 0.05 | 17 | ||
2023-11-08 | 2023-09-30 | 0.23 | 0.14 | -0.09 | 39 | ||
2023-08-30 | 2023-06-30 | 0.38 | 0.38 | 0.0 | 0 | ||
2023-05-03 | 2023-03-31 | 0.34 | 0.29 | -0.05 | 14 | ||
2023-02-08 | 2022-12-31 | 0.3 | 0.34 | 0.04 | 13 | ||
2022-11-09 | 2022-09-30 | 0.27 | 0.21 | -0.06 | 22 | ||
2022-08-24 | 2022-06-30 | 0.38 | 0.26 | -0.12 | 31 | ||
2022-05-04 | 2022-03-31 | 0.35 | 0.33 | -0.02 | 5 | ||
2022-02-09 | 2021-12-31 | 0.33 | 0.37 | 0.04 | 12 | ||
2021-11-02 | 2021-09-30 | 0.29 | 0.25 | -0.04 | 13 | ||
2021-08-25 | 2021-06-30 | 0.31 | 0.32 | 0.01 | 3 | ||
2021-05-06 | 2021-03-31 | 0.34 | 0.34 | 0.0 | 0 | ||
2021-02-03 | 2020-12-31 | 0.27 | 0.34 | 0.07 | 25 | ||
2020-11-04 | 2020-09-30 | 0.23 | 0.27 | 0.04 | 17 | ||
2020-08-26 | 2020-06-30 | 0.22 | 0.17 | -0.05 | 22 | ||
2020-05-07 | 2020-03-31 | 0.34 | 0.38 | 0.04 | 11 | ||
2020-02-03 | 2019-12-31 | 0.29 | 0.34 | 0.05 | 17 | ||
2019-11-04 | 2019-09-30 | 0.24 | 0.19 | -0.05 | 20 | ||
2019-08-27 | 2019-06-30 | 0.36 | 0.33 | -0.03 | 8 | ||
2019-05-06 | 2019-03-31 | 0.43 | 0.39 | -0.04 | 9 | ||
2019-02-06 | 2018-12-31 | 0.43 | 0.41 | -0.02 | 4 | ||
2018-11-06 | 2018-09-30 | 0.41 | 0.39 | -0.02 | 4 | ||
2018-08-27 | 2018-06-30 | 0.42 | 0.46 | 0.04 | 9 | ||
2018-05-07 | 2018-03-31 | 0.44 | 0.46 | 0.02 | 4 | ||
2018-02-05 | 2017-12-31 | 0.38 | 0.44 | 0.06 | 15 | ||
2017-11-06 | 2017-09-30 | 0.37 | 0.38 | 0.01 | 2 | ||
2017-08-30 | 2017-06-30 | 0.33 | 0.39 | 0.06 | 18 | ||
2017-05-08 | 2017-03-31 | 0.34 | 0.37 | 0.03 | 8 | ||
2017-02-06 | 2016-12-31 | 0.35 | 0.39 | 0.04 | 11 | ||
2016-11-09 | 2016-09-30 | 0.34 | 0.36 | 0.02 | 5 | ||
2016-08-29 | 2016-06-30 | 0.38 | 0.4 | 0.02 | 5 | ||
2016-05-09 | 2016-03-31 | 0.43 | 0.38 | -0.05 | 11 | ||
2016-02-09 | 2015-12-31 | 0.4 | 0.39 | -0.01 | 2 | ||
2015-11-09 | 2015-09-30 | 0.41 | 0.44 | 0.03 | 7 | ||
2015-09-09 | 2015-06-30 | 0.38 | 0.44 | 0.06 | 15 | ||
2015-05-11 | 2015-03-31 | 0.36 | 0.41 | 0.05 | 13 | ||
2015-02-10 | 2014-12-31 | 0.36 | 0.35 | -0.01 | 2 | ||
2014-11-11 | 2014-09-30 | 0.35 | 0.51 | 0.16 | 45 | ||
2014-09-16 | 2014-06-30 | 0.27 | 0.22 | -0.05 | 18 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Dividend Share 0.48 | Earnings Share 0.43 | Revenue Per Share | Quarterly Revenue Growth 0.126 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.